Email ID
Password
Sign me in automatically next time
Scrip Regulatory Affairs
Regulating Off-label Use in Hungary
21 October 2009
Tamás L Paál

Tamás Paál describes the country’s new unique regulatory procedure for officially authorising off-label prescriptions.

In the European Union, off-label prescribing is not regulated by Community law. Having left the legal interpretation up to the competent authorities in individual member states, the European legislation governing medicinal products for human use (Directive 2001/83/EC as amended) states only that a “Member State may, in accordance with legislation in force and to fulfil special needs, exclude from the provisions of this Directive medicinal products supplied in response to a bona fide unsolicited order…, for use by an individual patient under his direct personal responsibility”...

Please login to read the full article.
 
 
 
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
   
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36